Epidemiology, diagnosis and management of intracranial atherosclerotic disease

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 10, 2010, Pages 1423-1432

  Jeng, Jiann Shing ^a   Tang, Sung Chun ^a   Liu, Hon Man ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

angioplasty; cerebral ischemia; intracranial atherosclerosis; intracranial stenosis; risk factors; stenting; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; PLACEBO; WARFARIN;

ADD ON THERAPY; ANGIOPLASTY; BLEEDING; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG FATALITY; HUMAN; HYPERTENSION; INTRACRANIAL ATHEROSCLEROTIC DISEASE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PREVALENCE; RADIODIAGNOSIS; REVIEW; STENT; STROKE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGE FACTORS; ANGIOPLASTY; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS; STENTS; STROKE;

EID: 77958100730     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.129     Document Type: Review

References (94)

1. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study Stroke 26, 14-20 (1995).
2. Sacco RL, Adams R, Albers G et al.; American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affrms the value of this guideline. Stroke 37, 577-617 (2006).
3. Kuller L, Resiler DM. An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am. J. Epidemiol. 93, 1-9 (1971).
4. Feldmann E, Daneault N, Kwan E et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 40, 1541-1545 (1990).
5. Fields WS, Lemak NA. Joint study of extracranial arterial occlusion. X. Internal carotid artery occlusion. JAMA 235, 2734-2738 (1976).
6. Gorelick PB, Han J, Huang Y, Wong KS. Epidemiology. In: Intracranial Atherosclerosis. Kim JS, Caplan LR, Wong KS (Eds). Wiley-Blackwell, NJ, USA, 33-44 (2008).
7. Suri MFK, Johnston SC. Epidemiology of intracranial stenosis. J. Neuroimaging 19, 11S-16S (2009).
8. Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 34, 54-59 (1984).
9. Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D. Racial differences in the distribution of posterior circulation occlusive disease. Stroke 16, 785-790 (1985).
10. White H, Boden-Albala B, Wang C et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111, 1327-1331 (2005).
11. Markus HS, Khan U, Birns J et al. Differences in stroke subtypes between black and white patients with stroke. The South London Ethnicity and Stroke Study. Circulation 116, 2157-2164 (2007).
12. Weimer C, Goertler M, Harms L, Diener HC; for the German Stroke Study Collaboration. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch. Neurol. 63, 1287-1291 (2006).
13. Weber R, Kraywinkel K, Diener HC, Weimer C; on behalf of the German Stroke Study Collaboration. Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia. Cerebrovasc. Dis. 30, 188-193 (2010).
14. Kim JT, Yoo SH, Kwon JH, Kwon SU, Kim JS. Subtyping of ischemic stroke based on vascular imaging: ana lysis of 1167 acute, consecutive patients. J. Clin. Neurol. 2, 225-230 (2006).
15. Takahashi K, Kitani M, Fukuda H, Kobayashi S. Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA). Acta Neurol. Scand. 100, 395-399 (1999).
16. Liu HM, Tu YK, Yip PK, Su CT. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experiences. Stroke 27, 650-653 (1996).
17. Huang YN, Gao S, Li SW et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 48, 524-525 (1997).
18. Wong KS, Li H, Chan YL et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 31, 2641-2647 (2000).
19. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 22, 37-40 (2003).
20. De Silva DA, Woon FP, Lee MP et al. South Asia patients with ischemic stroke. Intracranial large arteries are the predominant site of disease. Stroke 38, 2592-2594 (2007).
21. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 39, 2396-2399 (2008).
22. Wong KS. Global burden of intracranial atherosclerosis. Int. J. Stroke 1, 158-159 (2006).
23. Qureshi AI, Feldmann E, Gomez CR et al. Intracranial atherosclerotic disease: an update. Ann. Neurol. 66, 730-738 (2009).
24. Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 39, 1142-1147 (2008).
25. Swartz RH, Bhuta SS, Farb RI et al. Intracranial arterial wall imaging using high-resolution 3-Tesla contrast-enhanced MRI. Neurology 17, 627-634 (2009).
26. Uehara T, Tabuchi M, Mori E. Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur. J. Neurol. 12, 218-222 (2005).
27. Park KY, Chung CS, Lee KH et al. Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic Korean population. J. Clin. Neurol. 2, 29-33 (2006).
28. Wong KS, Huang YN, Yang HB et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology 68, 2031-2034 (2007).
29. Wong KS, Ng PW, Tang A, Liu R, Yeung V, Tomlinson B. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 68, 2035-2038 (2007).
30. Huang HW, Guo MH, Lin RJ et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc. Dis. 24, 111-115 (2007).
31. Elmore EM, Mosquera A, Weinberger J. The prevalence of asymptomatic intracranial large-vessel occlusive disease: the role of diabetes. J. Neuroimaging 13, 224-227 (2003).
32. Nahab F, Cotsonis G, Lynn M et al. Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke 39, 1039-1041 (2008).
33. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 17, 648-655 (1986).
34. Initari D, Hachinski VC, Wayne TD, Barnett HJM. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factor? Arch. Neurol. 47, 1080-1084 (1990).
35. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27, 1974-1980 (1996).
36. Bae HJ, Lee J, Park JM et al. Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc. Dis. 24, 355-360 (2007).
37. Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur. J. Neurol. 14, 379-386 (2007).
38. Bang OY, Kim JW, Lee JH et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 65, 295-298 (2005).
39. Lee SJ, Cho SJ, Moon HS et al. Combined extracranial and intracranial atherosclerosis in Korean patients. Arch. Neurol. 60, 1561-1564 (2003).
40. Leung SY, Ng THK, Yuen ST, Lauder IJ, Ho FCS. Pattern of cerebral atherosclerosis in Hong Kong Chinese: severity in intracranial and extracranial vessels. Stroke 24, 779-786 (1993).
41. Arenillas JF, Molina CA, Chacon P et al. High lipoprotein(a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 63, 27-32 (2004).
42. Yasaka M, Yamaguchi T, Shichiri M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke 24, 206-211 (1993).
43. Moossy J. Pathology of cerebral atherosclerosis. Infuence of age, race, and gender. Stroke 24, I22-23, I31-32 (1993).
44. Obviagele B, Saver JL, Lynn MJ, Chimowitz M; for the WASID Study Group. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherosclerosis. Neurology 66, 1344-1349 (2006).
45. Rincon F, Sacco RL, Kranwinkel et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study Cerebrovasc. Dis. 28, 65-71 (2009).
46. Chimowitz MI, Lynn MJ, Howlett-Smith H et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 352, 1305-1316 (2005).
47. Obviagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI, for the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch. Neurol. 65, 733-737 (2008).
48. Mazighi M, Tanasescu R, Ducrocq X et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 66, 1187-1191 (2006).
49. Kasner SE, Chimowitz MI, Lynn MJ et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 13, 555-563 (2006).
50. Chaturvedi S, Turan TN, Lynn MJ et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 69, 2063-2068 (2007).
51. Williams JE, Chimowitz MI, Cotsonis GA, Lynn MJ, Waddy SP; for the WASID Investigators. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke 38, 2055-2062 (2007)
52. Rundek T Do women have worse outcome after stroke caused by intracranial arterial stenosis? Stroke 38, 2025-2027 (2007).
53. Feldmann E. Diagnosis and quantitation of intracranial stenosis. J. Neuroimaging 19, 22S-24S (2009).
54. Kaufmann TJ, Huston J, Mandrekar JN, Schleck CD, Thielen KR, Kallmes DF. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 243, 812-819 (2007).
55. Feldmann E, Wilterdink JL, Kosinski A et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 68, 2099-2106 (2007).
56. Krejza J, Mariak Z, Babikian VL. Importance of angle correction in the measurement of blood fow velocity with transcranial Doppler sonography. AJNR Am. J. Neuroradiol. 22, 1743-1747 (2001).
57. Baumgartner RW, Mattle HP, Schroth G. Assessment of ≥50% and <50% Intracranial stenoses by transcranial color-coded duplex sonography. Stroke 30, 87-92 (1999)
58. Arenillas JF, Molina CA, Montaner J et al. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study Stroke 32, 2898-2904 (2001).
59. Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 33, 532-536 (2002).
60. Arenillas JF, Alvarez-Sabín J, Molina CA et al. Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinfammatory state and impaired fbrinolysis. Stroke 39, 1456-1463 (2008).
61. Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J. Neuroimaging DOI: 10.1111/j.1552-6569.2009.00442.x (2009) (Epub ahead of print).
62. Meyers PM, Schumacher HC, Gray WA et al. Intravascular ultrasound of symptomatic intracranial stenosis demonstrates atherosclerotic plaque with intraplaque hemorrhage: a case report. J. Neuroimaging 19, 266-270 (2009).
63. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 115, 2969-2975 (2007).
64. Kwon SU, Cho YJ, Koo JS et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 36, 782-786 (2005).
65. Gao S, Wong KS, Hansberg T, Lam WW, Droste DW, Ringelstein EB. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 35, 2832-2836 (2004).
66. Wong KS, Chen C, Fu J et al.; CLAIR study investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 9, 489-497 (2010).
67. Turan TN, Maidan L, Cotsonis et al. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 40, 505-509 (2009)
68. The EC-IC Bypass study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N. Engl. J. Med. 313, 1191-1200 (1985).
69. Amin-Hanjani S, Charbel FT Is extracranial-intracranial arterial bypass surgery effective in certain patients? Neurol. Clin. 24, 729-743 (2006).
70. Barnett HJM. Hemodynamic cerebral ischemia. An appeal for systematic data gathering prior to a new EC/IC trial. Stroke 28, 1857-1860 (1997).
71. Grubb RL Jr, Powers WJ, Derdeyn CP, Adams HP, Clarke WR. The Carotid Occlusion Surgery Study. Neurosurg. Focus 14, e9 (2003).
72. Ogasawara K, Ogawa A. Japanese EC-IC Bypass Trial (JET study). Nippon. Rinsho. 64, 524-527 (2006).
73. Sundt TM, Smith HC, Campbell JK, Vietstra RE, Gucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin. Proc. 55, 673-680 (1980).
74. Siddiq F, Vazquez G, Memon MZ et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases. A multicenter study. Stroke 39, 2505-2510 (2008).
75. Marks MP, Wojak JC, Al-Ali F et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 37, 1016-1020 (2006).
76. Siddiq F, Memon MZ, Vazquez G, Safdar A, Qureshi AI. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-ana lysis of case series. Neurosurgery 65, 1024-1033 (2009).
77. The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35, 1388-1392 (2004).
78. Bose A, Hartmann M, Henkes H et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 38, 1531-1537 (2007).
79. Fiorella D, Levy EI, Turk AS et al. US multi-center experience with the Wingspan Stent System for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 38, 881-887 (2007).
80. Levy EI, Turk AS, Albuquerque FC et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61, 644-650 (2007).
81. Samaniego EA, Hetzel S, Thirunarayanan S, Aagaard-Kienitz B, Turk AS, Levine R. Outcome of symptomatic intracranial atherosclerotic disease. Stroke 40, 2983-2987 (2009).
82. Gröschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 40, e340-e347 (2009).
83. Qureshi AI, Hussein HM, El-Gengaihy A, Abdelmoula M, Suri MF. Concurrent comparison of outcomes of primary angioplasty and of stent placement in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 62, 1053-1060 (2008).
84. Moskowitz SI, Kelly ME, Obuchowski N, Fiorella D. Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital. J. Neurointervent. Surg. 1, 165-167 (2009).
85. Lylyk P, Vila JF, Miranda C et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol. Res. 27(Suppl. 1), S84-S88 (2005).
86. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61, 236-242 (2007).
87. Jiang WJ, Xu XT, Du B et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 68, 420-426 (2007).
88. Suh DC, Kim JK, Choi JW et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. Am. J. Neuroradiol. 29, 781-785 (2008).
89. Zaidat OO, Klucznik R, Alexander MJ et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 70, 1518-1524 (2008).
90. Miao ZR, Feng L, Li S et al. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery 64, 79-84 (2009).
91. Wolfe TJ, Fitzsimmons BF, Hussain SI, Lynch JR, Zaidat OO. Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases. J. Neurointervent. Surg. 1, 40-43 (2009).
92. Nahab F, Lynn MJ, Kasner SE et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 72, 2014-2019 (2009).
93. Kurre W, Berkefeld J, Brassel F et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke 41, 494-498 (2010).
94. Lutsep HL. Symptomatic intracranial stenosis: best medical treatment vs. intracranial stenting. Curr. Opin. Neurol. 22, 69-74 (2009).